UnitedHealth Earnings Rise as Insurer Adjusts to Obamacare

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

surgeons
Thinkstock
UnitedHealth Group Inc. (NYSE: UNH) reported fourth-quarter and full-year 2014 results before markets opened Wednesday. The health insurance and benefits management firm reported diluted quarterly earnings per share (EPS) of $1.55 on revenues of $33.43 billion. In the same period a year ago, UnitedHealth reported EPS of $1.41 on net income of $31.12 billion. Fourth-quarter results also compare to the consensus estimates for EPS of $1.50 on revenues of $33.11 billion.

For the full year, UnitedHealth reported EPS of $5.70 on revenues of $130.47 billion, compared with EPS of $5.50 and revenues of $122.49 billion in 2013. Analysts had estimated EPS of $5.64 and revenues of $130.1 billion.

For 2015, the company forecast revenues in a range of $140.5 billion to $141.5 billion and EPS in a range of $6.00 to $6.25. Cash flow from operations was pegged at $8.0 billion to $8.4 billion.

Total enrollment numbers fell slightly year-over-year from 45.45 million to 44.99 million. Commercial enrollments dropped the most, from 30.16 million to 28.75 million. Medicare and Medicaid enrollment rose from 10.48 million to 11.81 million, and international enrollment slipped from 4.81 million to 4.43 million.

The consolidated medical care ratio fell by 0.6% to 80.9% for the year and fell by 1.4% to 79.8% in the fourth quarter.

The company grew its Medicare and retirement revenues by 5% year-over-year to $11.5 billion in the quarter and $46.3 billion for the year. The employer and individual insurance business slipped about $1.8 billion to $43 billion for the year. Operating margin fell from 6.3% to 5.8% due to 85 basis points of pressure from Affordable Care Act Medicare rate cuts and other taxes and fees, partially offset by better operating performance and service margins.

Shares traded up about 3% in Wednesday’s premarket session, at $108.00 in a 52-week range of $69.57 to $106.38. The high was posted on Tuesday. Thomson Reuters had a consensus analyst price target of around $112.00 before the results were announced.

ALSO READ: Celgene Expects to More Than Triple Earnings by 2020

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618